lymphoproliferative disorders such as multiple myeloma, secondary neoplasia and infectious agents, as well as to determine staging of malignant neoplasia 1,2. Bone marrow aspiration is generally a ...

They may also want to test the liquid part of the bone marrow, called aspirate. There are several tests they can run on ...

Multiple myeloma (MM) invariably develops in the bone marrow (BM), indicating the strong requirement of this tumor for the peculiar BM microenvironment, rich in cytokine and hematopoietic ...

Medically reviewed by Lindsay Cook, PharmD Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer ...

The bone-marrow needle is ... result of a very thickly packed marrow, which resisted aspiration. Two cases in this series demonstrate the value of using multiple sites for confirmation of the ...

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients ...

July 1, 2024 — Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first ...

Multiple myeloma is a rare type of cancer. It starts with the uncontrolled production of plasma cells. These are a type of white blood cell in the bone marrow. Healthy plasma cells make antibodies ...

1 Multiple myeloma originates in blood plasma cells — a type of cell found in bone marrow that is responsible for making antibodies. When these plasma cells become cancerous, they multiply ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical ...